OriCol™ Achieves CE Marking Under EU Medical Device Regulation

Origin Sciences is pleased to announce that OriCol™, the innovative sampling device manufactured by TOGL, has successfully achieved CE marking under the European Union Medical Device Regulation (MDR 2017/745).

This milestone confirms OriCol™’s compliance with the EU’s rigorous standards for safety, performance and quality, and represents an important step in our mission to support wider adoption of OriCol™ sampling in clinical and community healthcare settings.

With CE marking in place, OriCol™ can now be made available across the European market, opening new opportunities to collaborate with clinicians, researchers and healthcare partners focused on advancing gastrointestinal health and earlier disease detection.

This achievement reflects the dedication and expertise of the teams involved, who have worked diligently to ensure full alignment with EU regulatory requirements. As we look ahead, OriCol™ is well positioned to support continued innovation in early detection and improved patient outcomes through an expanded presence in Europe.